January 18, 2023
Everwell Health Adds Key Leadership Roles
SADDLE BROOK, N.J., January 18, 2023 (Newswire.com) – Everwell Health is excited to announce two executive leaders that have recently joined the organization which further strengthens the company’s innovation capabilities and supports its long-term growth strategy. Volkan Eren has assumed the newly created role of Vice President, Sales & Business Development, while Catherine Kwik-Uribe will serve as Vice President of Scientific & Regulatory Affairs.
Mr. Eren will head the sales team and lead commercial strategy and sales administration. Volkan joins the organization from a unique background with fast-paced entrepreneurial businesses like Enzymotec, along with experience and roles of increased responsibility leading sales teams at larger scaled companies like Frutarom and IFF. Volkan’s prior role at IFF was Sales Leader for Supplements, Food, & Beverages. Volkan will focus on business expansion and diversification, as well as leading our sales organization. Volkan holds a bachelor’s degree in Business Administration & Management from Fairleigh Dickinson University and earned a master’s degree in Economics from City University of New York.
Dr. Kwik-Uribe is responsible for maintaining the excellent reputation that Nutrition21 (Everwell Health’s first platform investment) has earned throughout the years, while creating new strategies to build expertise, ideas, and processes that support the platform’s “science-first” approach. Catherine comes from a successful career at Mars Incorporated, her most recent role as VP, Scientific & Regulatory Affairs, Applied Science & Nutrition for Mars Edge. Catherine has worked across multiple product categories and led scientific teams of all sizes, conducted extensive research in human health and nutrition, and led the translation of science into consumer-relevant claims. Her expertise will drive the company’s clinical research needs and support new product claims and regulatory approvals in the U.S and international markets. Dr. Kwik-Uribe earned her Ph.D. in Human Nutrition from University of California, Davis and completed her post-doctoral training in toxicology at the University of California, Santa Cruz. Catherine has authored and co-authored more than 40 publications on the analysis, safety, and efficacy of nutrients and bioactive constituents in foods.
Both executives also bring M&A experience that will be important as Everwell Health invests to expand the platform. Steve Rosenman, CEO of Everwell Health commented, “These new leaders compliment our existing team at Nutrition21. Their experience and success, both at nimble, high growth companies and at highly professional, scaled global enterprises will support Everwell Health’s dual growth strategy of optimizing organic opportunities at Nutrition21, while aggressively developing strategic partnerships and pursuing external business development. These roles align with our commitments and continued investments in science, and in capabilities to serve our customers and help them grow.”
About Everwell Health
Everwell Health aims to help people look, feel and perform their best by advancing the science of safe, convenient and attainable functional ingredients. The company adds meaningful value to dietary supplement, food and beverage brands by offering scientifically substantiated functional ingredient solutions. The company is actively focused on business development partnerships across the functional ingredients market.
For more information on Everwell Health, visit: Everwellhealth.com
About Nutrition21, LLC
Nutrition21 is an industry-leading developer and marketer of efficacious, high-value, clinically substantiated ingredients for use in dietary supplements, functional foods and beverages. With decades of experience, the company’s scientific platform has continued to create unique, patented products that are both safe and clinically effective. To build consumer trust, Nutrition21 ensures product efficacy and safety through a product development process that involves rigorous preclinical and clinical research. The company currently holds over 70 domestic and international issued and pending patents for its ingredients which support unique claims associated with sports nutrition, weight management, cognitive health, and beauty-from-within, among others.
For more information on Nutrition21, visit Nutrition21.com
Original Source: www.newswire.com
more news
March 6, 2024
Nutrition21 Reports Cognitive Health Segment Poised for Exceptional Growth
SADDLE BROOK, NJ - Nutrition21 recently shared new insight into the cognitive health category, noting it is poised to be one of the……
September 27, 2023
Nutrition21 Expands Its nooLVL Functional Ingredient Into the Brain Health Space With Unique Scientifically Substantiated Cognitive Claims
SADDLE BROOK, N.J. (Newswire.com) - Nutrition21 announced the launch of its nootropic ingredient nooLVL® into the cognitive health space.
July 13, 2023
Nutrition21’s Velositol Wins the NutraIngredients-USA ‘Hector Lopez Excellence in Sports Nutrition Science Award’
SADDLE BROOK, N.J. (Newswire.com) - Nutrition21 LLC is proud to announce that Velositol®, its patented, clinically backed complex of…
June 30, 2023
Nutrition21’s Lustriva® Available Nationwide in U.S. Retail Stores
SADDLE BROOK, NJ - Nutrition21 LLC is proud to announce that its patented, clinically-backed beauty from within ingredient, Lustriva® is…
April 13, 2023
Nutrition21 to Showcase Lustriva at NYSCC Supplier’s Day Show
SADDLE BROOK, N.J. (Newswire.com) - Nutrition21 LLC will be exhibiting at the New York Society of Cosmetic Chemists (NYSCC) "Suppliers' Day…
October 10, 2022
Novel Beauty-From-Within Ingredient Lustriva® is Self-Affirmed as GRAS
SADDLE BROOK, N.J., October 10, 2022 (Newswire.com) – Nutrition21 LLC’s beauty-from-within ingredient, Lustriva®, has obtained…
April 8, 2022
New Study Presented at Experimental Biology (Poster: E380) Shows nooLVL® Improves Cognitive Functioning in Esports Gamers
Saddle Brook, NJ: Nutrition21, LLC (“Nutrition21”) recently conducted multiple computer-based cognitive tests through the online platform…
December 21, 2021
University of Arkansas Publishes a New Study on the Cognitive Benefits of Nutrition21’s Sports Performance Ingredient, Nitrosigine®
Harrison, New York: Nutrition21, LLC (“Nutrition21”) announced today that new research on the cognitive benefits of Nitrosigine®, a…
November 10, 2021
RoundTable Healthcare Partners Establishes Everwell Health, a New Functional Ingredients Platform Serving the Consumer Healthcare Market
LAKE FOREST, IL, November 10, 2021 – RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm focused…
Nutrition21 Proudly Supports the Following Industry Associations
©2024 Nutrition21, LLC. All rights reserved.
Nitrosigine®, Velositol®, nooLVL®, Lustriva®, Chromax®, Zinmax®, and their associated logos are registered trademarks of Nutrition21, LLC. All third party trademarks are the property of their respective owners. Nutrition21, LLC's products are protected by a number of patents including, but not limited to: US Patent Nos. 6,809,115; 6,803,456; 7,576,132; 8,062,677; 8,933,022; 9,028,879; 9,119,835; 9,597,404; 9,675,702; 10,183,049; and 10,245,325.